cGMP vs. ISO/IEC 17025: Two Standards, Two Different Questions

Quality language in this industry tends to arrive as a pair of acronyms, dropped together, and then never explained. cGMP and ISO/IEC 17025 are the two that matter most — and they answer two genuinely different questions about a product.

A supplier can plausibly satisfy one and not the other. When that happens, the gap is exactly where problems show up.

cGMP answers: was it made the same way every time?

Current Good Manufacturing Practice is a framework for production. Its purpose is not to prove that a batch is pure — that is testing's job. Its purpose is to make purity reproducible.

In practice, cGMP means documented procedures that operators actually follow, controlled environmental conditions, raw materials that are themselves qualified, batch records that capture what happened during production, change control so that a process modification is reviewed before it ships, trained personnel, and a defined route for handling deviations and complaints.

The word 'current' is part of the standard for a reason. It refers to equipment, methods, and practices that are up to date rather than inherited from a previous decade.

ISO/IEC 17025 answers: can you trust the measurement?

ISO/IEC 17025 is a competence standard for laboratories, not for manufacturers. It says nothing about how material was produced. It says a great deal about whether a number on a report can be believed.

Accreditation covers method validation, instrument calibration and maintenance, measurement traceability to recognized reference standards, operator qualification, proficiency testing against peer laboratories, and documented quality management within the lab itself.

This matters because a COA is only as good as the instrument and the technique that produced it. An unaccredited laboratory can produce a beautifully formatted document that is quietly wrong.

Why you need both, and why independence matters

Manufacturing controls and testing competence are complementary, not redundant. Strong cGMP with weak analytical capability means a facility that is consistent but unable to verify its own consistency. Strong analytical capability in a facility with no manufacturing discipline means accurate measurements of a process that drifts from batch to batch.

The final layer is separation. Testing performed by an organization other than the one that made the material removes the incentive to interpret an ambiguous result generously. This is why PSG specifies independent ISO/IEC 17025 accredited testing rather than accepting a manufacturer's internal report.

How to check a supplier's claims

When you are evaluating a source, these four questions produce an immediate answer about how the operation runs:

• Ask what quality framework the manufacturing facility follows, and whether that is a claim or an auditable status.
• Ask which laboratory performed release testing, and whether that laboratory is accredited to ISO/IEC 17025.
• Ask whether the accreditation is for the laboratory or merely for a quality management system — these are different scopes.
• Ask whether documentation is issued per lot or per product line.

Every compound PSG distributes is manufactured to cGMP standards in the United States and tested by an independent laboratory accredited to ISO/IEC 17025. That is the same standard of evidence we would want if we were the buyer, so we state it plainly and document it per lot.

A note on scope

Peptide Source Group is a wholesale distributor and marketing support company. We are not doctors and do not provide medical advice or recommendations. References to manufacturing and testing standards describe supply chain quality controls, not clinical claims.